Maligne Systemerkrankungen

  • K. Musshoff
  • J. Slanina

Zusammenfassung

Unter dem Begriff der malignen Systemerkrankungen verstehen wir die Neoplasien des lymphoreticulären und myeloischen Gewebes. Besonders in den letzten 10 Jahren wurden die Bemühungen intensiviert, Fragen der Ätiologie, Epidemiologie, histopathologi-schen Klassifikation und klinischen Stadieneinteilung dieser Erkrankungen zu klären, um die Voraussetzungen für verbesserte Behandlungsverfahren, insbesondere auch den adäquaten Einsatz der Strahlentherapie, zu schaffen. Bei den malignen Lymphomen leisteten Arbeiten über die Hodgkinsche Erkrankung Schrittmacherdienste. Sie sind beispielhaft für interdisziplinäres und internationales Teamwork, dokumentiert in einer Reihe von Symposien und Konferenzen, die 1965 in Paris (1966) und Rye/New York (1966), in Ann Arbor (1971), 1972 in Stanford (1973), 1973 in London (1975) und 1976 in San Francisco (1977) abgehalten wurden. Als Ergebnis verfügen wir heute bei der Hodgkinschen Erkrankung über klare Konzepte der histologischen und klinischen Klassifikation und damit über Richtlinien für eine bestmögliche Therapie. Der Fortschritt dokumentiert sich in einer signifikanten Verbesserung der Lebenserwartung und in einem hohen Prozentsatz von Heilungen dieser bis dahin unheilbaren Erkrankung.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abbatucci JS, van der Werf-Messing B (1975) EORTC Radio-Chemotherapy Cooperative Group. Clinical trial using radiotherapy and chemotherapy in Non-Hodgkin-Lymphoma. Chairman: Abbatucci JS. Study Secretary: van der Werf-Messing B. Protocol 20751, June 1975Google Scholar
  2. Aigner K, Dobroschke J, Schwemmle K (1978) Splenektomie bei malignen Lymphomen aus chirurgischer Sicht. Klinikarzt 7: 888–893Google Scholar
  3. Airlie House Warrenton, Virginia (1975) Invitational workshop for the planning of retrospective and prospective studies to delineate optimal classfications of the Non-Hodg-kin’s lymphomas. September 4–5 (1975)Google Scholar
  4. Andersen V, Weeke E, Killmann SA (1974) Extracorporal irradiation of the blood: clinical applications, Strahlentherapie 148: 603–613PubMedGoogle Scholar
  5. Arndt J (1973) Indikationen und Grenzen der Strahlentherapie bösartiger Neubildungen. Fischer, StuttgartGoogle Scholar
  6. Arseneau JC, Canellos GP, Johnson RJ, DeVita VT (1977) Risk of new cancers in patients with Hodgkin’s disease. Cancer 40: 1912–1916PubMedGoogle Scholar
  7. Banfi A, Bonadonna G, Carnevali G, Oldini C, Salvini E (1968) Preferential sites of involvement and spread in malignant lymphomas. Europ J Cancer 4: 319–324Google Scholar
  8. Bauer R (1959) Die Strahlenbehandlung der Hämoblastosen. Strahlenforschung und Krebsbehandlung. Strahlentherapie Sonderbd 43: 223–236Google Scholar
  9. Begemann H, Harwerth H-G (1967) Praktische Hämatologie, 3. Aufl. Thieme, Stuttgart, S 134–139Google Scholar
  10. Begemann H, Theml H (1978) Zur Frage der Splenektomie bei der Lymphogranulomatose (Morbus Hodgkin) — Pathophysiologische und klinische Gesichtspunkte. Klinikarzt 7: 714–724Google Scholar
  11. Begemann H, Rastetter J, Kaboth W (1970) Klinische Hämatologie. Thieme, StuttgartGoogle Scholar
  12. Bennett MH (1975) Sclerosis in Hon-Hodgkin’s lymphomata. Brit J Cancer 31, Suppl II: 44–52Google Scholar
  13. Bennett MH, Millet YL (1969) Nodular sclerotic lymphosarcoma, a possible new clinico-pathological entity. Clin Radiol 20: 339PubMedGoogle Scholar
  14. Bitran JD, Kinzie J, Sweet DL, Variakojis D, Griem ML, Golomb HM, Miller JB, Noetzel N, Ultmann JE (1977) Survival of patients with localized histiocytic lymphoma. Cancer 39: 342–346PubMedGoogle Scholar
  15. Bonadonna G, Uslenghi C, Zucali R (1975) Recent trends in the medical treatment of Hodgkin’s disease. Europ J Cancer 11: 251–266Google Scholar
  16. Bopp JH, Günther D (1970) Die Strahlenbehandlung des eosinophilen Granuloms. Strahlentherapie 140: 143–147PubMedGoogle Scholar
  17. Bousser J, Bilski-Pasquier G, Blane C (1967) Vergleichende Untersuchungen zur Behandlung der chronischen myeloischen Leukämie mit Röntgenstrahlen und Myleran. Deutscher Röntgenkongreß 1966. Sonderband zur Strahlentherapie, Teil B: 271–275Google Scholar
  18. Brittinger G, Bartels H, Bremer K, Dühmke E, Gunzer U, König E, Stein H (1976) Klinik der malignen Non-Hodgkin-Lymphome entsprechend der Kiel-Klassifikation: Centrocytisches Lymphom, centroblastisch-centrocytisches Lymphom, lymphobla-stisches Lymphom, immunoblastisches Lymphom. In: Löffler H (Hrsg) Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd 18. Lehmann, München, S 211–223Google Scholar
  19. Brittinger G, Bartels H, Bremer K, Burger A, Dühmke E, Gunzer U, König F, Schmalhorst U, Stacher A, Stein H, Theml H, Waldener R (Kieler Lymphomgruppe) (1978) Klinische Bedeutung der Kiel-Klassifikation der malignen Non-Hodgkin-Lymphome. In: Hartwich G (Hrsg) Diagnose und Therapie von Leukämien und malignen Lymphomen. Straube, Erlangen, S 57–66Google Scholar
  20. Brittinger G, Bartels H, Burger A, Dühmke E, Fülle HH, Gunzer U, Heinz R, Huhn D, Löhr GW, Musshoff K, Nowicki L, Pfoch M, Pralle H, Schmalhorst U (Kieler Lymphomgruppe (1979) Grundlagen und bisherige Ergebnisse der prospektiven Studie der Kieler Lymphomgruppe über Non-Hodgkin-Lymphom. In: Stacher A, Höcker P (Hrsg) Lymphknotentumoren. Urban & Schwarzenberg, München Wien Baltimore, S 193–200Google Scholar
  21. Brown TC, Peters MV, Bergsagel DE, Reid J (1975) A retrospective analysis of the clinical results in relation to the Rappaport histological classification. Symposium on Non-Hodgkin’s lymphomata. London, October 8–12, 1973. Brit J Cancer 31, Suppl II: 174–186Google Scholar
  22. Brunner H (1942) Nasopharyngeal fibroma. Ann Otol Rhinol Laryngol 51: 29–65Google Scholar
  23. Bruntsch U, Beersik F, Eigler FW, Grub R, van Lessen H, Löhr GW, Musshoff K, Schmidt CG, Slanina J (1977) Primäre und sekundäre explorative Laparatomie und Splenektomie bei Lymphogranulomatose. Dtsch Med Wochenschr 102:1799–1804PubMedGoogle Scholar
  24. Butler JJ (1971) Relationship of histological findings to survival in Hodgkin’s disease. Cancer Res 31: 1170–1775Google Scholar
  25. Cadman EC, Capizzi RL, Bertino JR (1977) Acute nonlymphocytic leukemia. A delayed complication of Hodgkin’s disease therapy: analysis of 109 cases. Cancer 40: 1280–1296PubMedGoogle Scholar
  26. Canellos GP, Young RC, DeVita VT (1972) Combination chemotherapy for advanced Hodgkin’s disease in relaps following extensive radiotherapy. Clin Pharmacol Ther 13: 750–754Google Scholar
  27. Candios GP, De Vita VT, Young RC, Chabner BA, Schein PS, Johnson RE (1975a) Therapy of advanced lymphocytic lymphoma; a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy. Brit J Cancer 31, Suppl II: 474–480Google Scholar
  28. Canellos G, De Vita VT, Arseneau JC, Whang-Peng J, Johnson REC (1975b) Second malignancies complicating Hodgkin’s disease in remission. Lancet 2: 947–949Google Scholar
  29. Carbone P-P (1972) Non-Hodgkin’s lymphoma: recent observations on natural history and intensive treatment. Cancer (Philadelphia) 30: 1511–1515Google Scholar
  30. Carbone PP, Kaplan HS, Musshoff K, Smithers IW, Tubiana M (1971) Report of the Hodgkin’s disease staging classification committee. Conference on staging in Hodgkin’s disease. Ann Arbor, April 26–28, 1971. Cancer Res 31: 1860–1861PubMedGoogle Scholar
  31. Carbone PP, Spurr C (1968) Management of patients with malignant lymphoma. A comparative study with cyclophosphamide and vinca alcaloids. Cancer Res 28: 811–822PubMedGoogle Scholar
  32. Chaffey JT, Rosenthal DS, Pinkus G, Helmann S (1975) Advanced lymphosarcoma treated by total body irradiation. Brit J Cancer 31, Suppl II: 441–449Google Scholar
  33. Cheyne C (1971) Histiocytosis X. J. Bone Jt Surg 53 B: 366–382Google Scholar
  34. Chilcote RR, Baehner RL, Hammond D (1976) Septicemia and meningitis in children splenectomized for Hodgkin’s disease. Engl J Med 295: 798–800Google Scholar
  35. Conference on Non-Hodgkin’s lymphomas (San Francisco, Sept. 30-Oct. 2, 1976) Proceedings of the (1977) Jones StE, Godden J (eds). Cancer Treat Rep 935–1227Google Scholar
  36. Conklin R, Alexanian R (1975) Clinical classification of plasma cell myeloma. Arch Int Med 135: 139–143Google Scholar
  37. Cox JD (1978) Central lymphatic irradiation to low dose advanced nodular lympho-reticular tumors (Non-Hodgkin’s lymphoma). Radiology 126: 767–772PubMedGoogle Scholar
  38. Cox JD, Koehl RH, Turner WM, King FM (1974) Irradiation in the local control of malignant lymphoreticular tumors (Non-Hodgkin’s malignant lymphoma). Radiology 112: 179–185PubMedGoogle Scholar
  39. Craft CB (1940) Results with roentgen ray therapy in Hodgkin’s disease. Bull Staff Meet Univ Minn Hosp 11: 391–409Google Scholar
  40. Cronkite EP, Chanana AD, Schnappauf H (1965) Extracorporal irradiation of blood and lymph in animals: its effect on homografts and on lymphoma. New Engl J Med 272: 456–461PubMedGoogle Scholar
  41. Cronkite EP, Jansen CR, Cottier H, Rai K, Sipe CR (1964) Lymphocytic production measured by extracorporal irradiation, cannulation and labeling techniques. Ann NY Acad Sci 113:566–577PubMedGoogle Scholar
  42. Dancot H (1967) Über die Heilungsaussichten bei Lymphosarkomen und Retikulosarkomen durch Bestrahlung (Ergebnisse einer Untersuchung bei 395 Fällen). Deutscher Röntgenkongreß 1966, Teil B, Strahlenbehandlung und Strahlenbiologie. Sonderbände zur Strahlentherapie 64: 283Google Scholar
  43. Dancot H, Feremans W (1974) The curability of lympho- and reticulosarcomas. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 201–205Google Scholar
  44. D’Angio GJ, Evans AE, Mitus A (1959) Roentgentherapy of certain complications of acute leukemia in childhood. Amer J Roentgenol 82: 541–553PubMedGoogle Scholar
  45. Deelmann HT (1956) 1943–1954, zitiert nach Sluiter JFT: De histologie van de ziekte van Brill in haar verschillende phasen. Diss Med AmsterdamGoogle Scholar
  46. Del Regato JA (1941) Roentgentherapy of lymphosarcomas of the tonsil. Radiation Therapy Tumor Inst Seattle (No 2): 67–76Google Scholar
  47. Desser RK, Golomb HM, Ultmann JE, Ferguson DJ, Moran EM, Griem ML, Vardiman J, Kinzie JJ, Blough R (1977) Prognostic classification of Hodgkin’s disease in pathologic stage III based on anatomic considerations. Blood 49: 883–893PubMedGoogle Scholar
  48. De Vita VT, Serpick AA, Carbone PP (1970) Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Int Med 73: 881–895Google Scholar
  49. Djaldetti M, Devries A, Levi B, Patah T (1962) Haemolytic anaemia in lymphocytic leucaemia. Arch Intern Med 110: 449–455PubMedGoogle Scholar
  50. Dorfman RF (1971) Relationship of histology to site in Hodgkin’s disease. Cancer Res 31: 1786–1793PubMedGoogle Scholar
  51. Ellermann U, Bang O (1908) Experimentelle Leukämie bei Hühnern. Zbl Bakt 46:595–609Google Scholar
  52. Epstein MA, zur Hausen H, Bull G, Rabin H (1975) Pilot experiments with EB virus in owl monkeys. Int J Cancer 15: 17–22PubMedGoogle Scholar
  53. Falk LA, Wolfe LG, Deinhardt F (1971) Oncogenesis of Herpesvirus saimiri in marmosets. Fed Proc 30: 514Google Scholar
  54. Farber S (1941) The nature of “solitary or eosinophilic granuloma” of bone. Amer J Path 17: 625–629Google Scholar
  55. Farhangi M, Osserman EF (1973) The treatment of multiple myeloma. Sem Hematol 10: 149–161Google Scholar
  56. Finkelstein JZ, Dyment PG, Hammond GD (1969) Leukemic infiltration of the testes during bone marrow remission. Pediatrics 43: 1042–1045Google Scholar
  57. Fransilla KO, Kalima TV, Voutilainen A (1967) Histological classification of Hodgkin’s disease. Cancer (Philadelphia) 20: 1594–1601Google Scholar
  58. Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of extranodal lymphomas. Cancer (Philadelphia) 29: 252–260Google Scholar
  59. Fuks Z, Bagshaw MA (1971) Total skin electron treatment of mycosis fungoides. Radiology 100: 145–150PubMedGoogle Scholar
  60. Fuks Z, Bagshaw MA, Farber ME (1973) Prognostic signs and the management of the mycosis fungoides. Cancer (Philadelphia) 32: 1385–1395Google Scholar
  61. Fuller LM, Gamble JF, Butler JJ (1971) Influence of specific histology and clinical presentation on prognosis in localized Hodgkin’s disease treated with intensive large volume radiotherapy. J Radiol 98: 641–654Google Scholar
  62. Galbraith PR (1967) The mechanism of an action of splenic irradiation in chronic myelogenous leukemia. Canad Med Ass J 96: 1636–1641PubMedGoogle Scholar
  63. Gall EA, Mallory TB (1942) Malignant lymphoma: A clinical-pathological survey of 618 cases. Amer J Path 18: 381–429PubMedGoogle Scholar
  64. Gall EA, Rappaport M (1958) Seminar on diseases of lymph nodes and spleen. In: McDonald JE (ed) Proceedings of 23rd seminar, American Society of Clinical PathologyGoogle Scholar
  65. Galton DAG (1964) Chronic lymphocytic leukaemia: Its pathogenesis and relationship to lymphosarcoma. In: Roulet FC (ed) Symposium on lymphoreticular tumours in Africa, Paris 1963. Karger, Basel New York, pp 163–172Google Scholar
  66. Gerard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld AG, van Unnik JAM (1974) Classification on Non-Hodgkin’s lymphomas. Lancet 1974 II: 405–408Google Scholar
  67. Gilbert HA, Kagan AR (1978) Modern radiation oncology, Cap IV, Lymphomas. Harper & Row, Hagerstown New York San Fracisco London, pp 397–454Google Scholar
  68. Gilbert R (1939) Radiotherapy in Hodgkin’s disease (malignant granulomatosis): Anatomic and clinical foundations; governing principles; results. Amer J Roentgenol 41: 198–241Google Scholar
  69. Gilbert R, Babaiantz L (1931) Notre méthode de roentgenthérapie de la lymphogranu-lomatose (Hodgkin); résultats éloignés. Acta Radiol (Stockholm) 12: 523–529Google Scholar
  70. Glatstein E, Guernsey IM, Rosenberg SA, Kaplan HS (1969) The value of laparotomy and splenectomy in the staging of Hodgkin’s disease. Cancer 24: 709–718PubMedGoogle Scholar
  71. Glatstein E, Kim H, Donaldson SS, Dorfman RF, Gribble TJ, Wilbur JR, Rosenberg SA, Kaplan HS (1974) Non-Hodgkin’s lymphomas. VI. Results of treatment in childhood. Cancer (Philadelphia) 34: 204Google Scholar
  72. Glatstein E, Fuchs E, Goffinet DR, Kaplan HS (1976) Non-Hodgkin’s lymphoma of stage III extent. Is total lymphoid irradiation appropriate treatment? Cancer 37: 2806–2812PubMedGoogle Scholar
  73. Glatstein E, Portlock C, Rosenberg SA, Kaplan HS (1977) Combined modality treatment in the malignant lymphomas. Salmon SE, Jones SE (eds). Elsevier/North Holland, Amsterdam, pp 545–548Google Scholar
  74. Glick JH (1978) The treatment of stage III A Hodgkin’s disease: what is the role of combined modality therapy? Int J Radiat Oncol Biol Phys 4: 900–911Google Scholar
  75. Goffinet DR, Castellino RA, Kim H, Dorfman RF, Fuks Z, Rosenberg SA, Nelson T, Kaplan HS (1973) Staging laparatomy in unselected previously untreated patients with Non-Hodgkin’s lymphomas. Cancer (Philadelphia) 32: 672–691Google Scholar
  76. Goffinet DR, Glatstein E, Fuks Z, Kaplan HS (1976) Abdominal irradiation in Non-Hodgkin’s lymphomas. Cancer 37: 2797–2806PubMedGoogle Scholar
  77. Gough J (1970) Hodgkin’s disease; a correlation of histopathology with survival. Int J Cancer 5: 273–281PubMedGoogle Scholar
  78. Hamann W, Oehlert W, Musshoff K, Nuß A, Schnellbacher B (1970) Histologic classification of Hodgkin’s disease and its relevance to prognosis. Germ Med Monthly 15: 509–514Google Scholar
  79. Han T, Stutzmann K (1967) Mode of spread in patients with localized malignant lym-phome. Arch Intern Med 120: 1–7PubMedGoogle Scholar
  80. Hanks GE, Terry LN, Bryan JA, Newsome JF (1972) Contribution of diagnostic laparatomy to staging Non-Hodgkin’s lymphomas. Cancer (Philadelphia) 29: 41–43Google Scholar
  81. Hausen zur H, Schulte-Holthausen H (1972) Detection of Epstein-Barr viral genomes in human tumor cells by nucleic acid hybridization. In: Biggs PM, de The G, Payne LN (eds) Oncogenesis and Herpesvirus. International Agency for Research on Cancer, Lyons, pp 321–325Google Scholar
  82. Heilmeyer L, Begemann H (1961) Blut und Blutkrankheiten. In: Heilmeyer L (Hrsg) Lehrbuch der inneren Medizin, 2. Aufl. Springer, Berlin Göttingen Heidelberg, S 376–449Google Scholar
  83. Hellman S, Mauch P, Goodman RL, Rosenthal DS, Molloney W (1978) The place of the radiation therapy in the treatment of Hodgkin’s disease. Cancer 42: 971–978PubMedGoogle Scholar
  84. Hellstrom I, Hellstrom KE, Sjogren HD, Warner GA (1971) Demonstration of cell mediated immunity to human neoplasm of various histological types. Int J Cancer 7:1–6PubMedGoogle Scholar
  85. Henle W, Henle G (1973) Evidence for an oncogenic potential of the Epstein-Barr virus. Cancer Res 33: 1419–1423PubMedGoogle Scholar
  86. Hodgkin T (1832) On some morbid appearances of the absorbent gland and spleen. Med-Chir Trans 17: 68–114PubMedGoogle Scholar
  87. Hoeffken K, Schmidt CG (1976) Laparoskopie bei Morbus Hodgkin. Dtsch Med Wschr 101: 814–818Google Scholar
  88. Hohl K (1974) Present results in the treatment of malignant lymphomas. Results obtained in a series of 317 cases. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 233–239Google Scholar
  89. Jackson H, Parker F (1944) Hodgkin’s disease. I. General considerations. New Engl J Med 230: 1–8Google Scholar
  90. Jackson H Jr, Parker F Jr (1947) Hodgkin’s disease and allied disorders. Oxford Univ Press, New YorkGoogle Scholar
  91. Jeliff AM, Thomson AD (1955) The prognosis in Hodgkin’s disease. Brit J Cancer 9: 21–36Google Scholar
  92. Johnson RE (1973) Total nodal irradiation. J Amer Med Ass 223: 59–61Google Scholar
  93. Johnson RE (1975a) Total body irradiation (TBI) as primary therapy for advanced lymphosarcoma. Cancer (Philadelphia) 35: 242–246Google Scholar
  94. Johnson RE (1975b) Management of generalized malignant lymphoma with “systemic” radiotherapy, Brit J Cancer 31, Suppl II: 450–455Google Scholar
  95. Johnson RE, Rühl U (1976) Treatment of chronic lymphocytic leukemia with emphasis on total body irradiation. Int J Radiat Oncol Biol Phys 1: 387–397PubMedGoogle Scholar
  96. Johnson RE, De Vita VT, Kun LE, Chabner BR, Chretin PB, Berard CW, Johnson SK (1975) Patterns of involvement with malignant lymphoma and implications for treatment decision making. Brit J Cancer 31, Suppl II: 237–241Google Scholar
  97. Johnson RE, Glover MK, Marshall SK (1971) Results of radiation therapy and implications for the clinical staging of Hodgkin’s disease. Cancer Res 31:1834–1837PubMedGoogle Scholar
  98. Johnson RE, Thomas LB, Schneider M, Glenn DW, Faw F, Hafermann MD (1970) Preliminary experience with total nodal irradiation in Hodgkin’s disease. Radiology 96: 603–608PubMedGoogle Scholar
  99. Johnson RE, Rühl U, Brereton H (1975b) Radiation therapy of malignant lymphomas: Rationale techniques, results. Proceedings of the XI. International Cancer Congress, Florence 1974. Excerpta Medica International Congress Series 354: 374–379Google Scholar
  100. Johnson RE, Rühl U. Johnson SK, Glover M (1976) Split-course radiotherapy of Hodgkin’s disease. Cancer 37: 1713–1717PubMedGoogle Scholar
  101. Jones SE, Kaplan HS, Rosenberg SA (1972a) Non-Hodgkin’s lymphomas. III. Preliminary results of radiotherapy and a proposal for new clinical trials. Radiology 103: 657 – 662PubMedGoogle Scholar
  102. Jones SE, Rosenberg SA, Kaplan HS (1972b) Non-Hodgkin’s lymphomas. I. Bone marrow involvement. Cancer (Philadelphia) 29: 954–960Google Scholar
  103. Jones SE, Rosenberg SA, Kaplan HS, Kadin ME, Dorfman RF (1972c) Non-Hodkin’s lymphomas. II. Single agent chemotherapy. Cancer (Philadelphia) 30: 31–38Google Scholar
  104. Jones SE, Fuchs Z, Bull M, Kadin ME, Dorfman RF, Kaplan HS, Rosenberg SA, Kim H (1973) Non-Hodkin’s lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer (Philadelphia) 31: 806–825Google Scholar
  105. Jones SE, Godden J (eds) (1977) Proceecdings of the Conference on Non-Hodgkin’s Lymphomas. September 30 to October 2, 1976, San Francisco, California. Cancer Treat Rep 61: 935–1227Google Scholar
  106. Kaplan HS (1962) The radical radiotherapy of regionally localized Hodgkin’s disease. Radiology 78: 533–561Google Scholar
  107. Kaplan HS (1966) Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin’s disease. Cancer Res 26: 1221–1224PubMedGoogle Scholar
  108. Kaplan HS (1968) Prognostic significance of the relapse free Intervall after radiotherapy in Hodgkin’s disease. Cancer (Philadelphia) 22: 1131–1136Google Scholar
  109. Kaplan HS (1968–1969) On the natural history, treatment and prognosis of Hodgkin’s disease. The Harvey Lectures, Series 64: 215–259. Academic Press, New York, 1970Google Scholar
  110. Kaplan HS (1972) Hodgkin’s disease. Harvard Univ. Press, Cambridge/MassachusettsGoogle Scholar
  111. Kaplan HS (1973) Radiotherapy of advanced Hodgkin’s disease with curative intent. In: Rubin P (ed) Updated Hodgkin’s disease: B. Curability of localized disease. J Amer Med Ass 223: 50–52Google Scholar
  112. Kaplan HS (1978) In: Harvey AG, Kagan AR (eds) Modern radiation oncology: Hodgkin’s lymphomas commentary. Harper & Row, Haberstown New York San Francisco London, pp 418–427Google Scholar
  113. Kaplan HS, Dorfman RF, Nelsen TS, Rosenberg SA (1973) Staging laparotomy and splenectomy in Hodgkin’s disease. Analysis of indications and patterns of involvement in 285 consecutive unselected patients. Nat Cancer Inst Monogr 36: 291–301PubMedGoogle Scholar
  114. Kaplan HS, Dorfman RF, Nelsen TS, Rosenberg SA (1974) Staging laparotomy and splenectomy in Hodgkin’s disease. Analysis of indications and patterns of involvement in 285 consecutiveunselected cases. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 118–122Google Scholar
  115. Keller AR, Kaplan HS, Lukes RJ, Rappaport H (1968) Correlation of histopathology with other prognostic indicators in Hodgkin’s disease. Cancer (Philadelphia) 22: 487–499Google Scholar
  116. Klaue P, Gunzer U, Nürnberger R (1974) Operationsrisiko und diagnostischer Wert der explorativen Laparotomie und Splenektomie bei Morbus Hodgkin. Chirurg 45: 421–425PubMedGoogle Scholar
  117. Kleihauer Ü (1978) Hämatologie — Physiologie — Pathologie -Klinik. Springer, Berlin Heidelberg New YorkGoogle Scholar
  118. Klein G, Clifford G, Henle G, et al (1969) EBV-associated serological patterns in a Burkitt lymphoma patient during regression and recurrence. Int J Cancer 4: 416–421PubMedGoogle Scholar
  119. Koppenfels R v (1971) Klinische Erfahrungen im Plasmozytom unter besonderer Berücksichtigung der Röntgendiagnostik und der Strahlentherapie. Strahlentherapie 142: 276–285Google Scholar
  120. Kubik S (1974) The anatomy of the lymphatic system. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidleberg New York, pp 233–239Google Scholar
  121. Landberg T (1974) Radiosensitivity problems in mantle treatment of Hodkin’s disease, In: Lopez GJ, Monmati J, Berry RH, Hopewell JW (eds) Proceedings of the XIII. International Congress of Radiology, Madrid, October 15–20, 1973. Radiology 2: 115–116. Excerpta Medica, AmsterdamGoogle Scholar
  122. Landberg T, Forslo H (1970) Radiosensitivity of mediastinal lymphomas in Hodgkin’s disease treated with split-course radiotherapy. Acta Radiol Ther Phys Biol 9: 177–189PubMedGoogle Scholar
  123. Landberg T, Larsson LE (1969) Hodgkin’s disease. Retrospective clinico-pathologic study in 149 patients. Acta Radiol (Stockholm) 8: 390–414Google Scholar
  124. Landberg T, Garwicz S, Ackerman M (1975) A clinico-pathological study of Non-Hodg-kin’s lymphomata in childhood. Brit J Cancer 31, Suppl II: 332–336Google Scholar
  125. Lattuada A, Bonadonna G, Milani F, Banfi A, Valagussa P, De Lena M, Monfardini S (1977) Adjuvant chemotherapy with CVP after radiotherapy (RT) in stage I-II Non-Hodkin’s lymphomas. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer. Elsevier/North Holland, AmsterdamGoogle Scholar
  126. Leibfried H, Kerssenfischer V, Fiss N, Werner S (1975) Prognost. Untersuchung. Medizin Technik, BaselGoogle Scholar
  127. Lennert K (1953) Histologische Studien zur Lymphogranulomatose. I. Die Cytologie der Lymphogranulomzellen. Frankfurt Z Path 64: 209–234Google Scholar
  128. Lennert K (1967) Classification of malignant lymphomas (European Concept). In: Rüttimann A (ed) Progress in lymphology. Thieme, Stuttgart, pp 103–109Google Scholar
  129. Lennert K (1969) Pathologisch-anatomische Klassifikation der malignen Lymphome. In: Becker J, Gauwerky F (Hrsg) Maligne Lymphome. Urban & Schwarzenberg, München Berlin WienGoogle Scholar
  130. Lennert K (1973a) Pathologisch-histologische Klassifizierung der malignen Lymphome, Pathophysiologie, Klinik, Chemo- und Immuntherapie. Stacher A (Hrsg). Urban & Schwarzenberg, München Berlin Wien, S 181–1994Google Scholar
  131. Lennert K (1973b) Follicular lymphoma. A tumor of the germinal centers. In: Akazaki K, Rappaport H, Berard CW, Bennett JM, Ishikawa E (eds) Malignant diseases of the hematopoietic system. GANN Monograph on Cancer Research, vol 15. University of Tokyo Press, Tokyo, pp 217–231Google Scholar
  132. Lennert K (1976) Klassifikation und Morphologie der Non-Hodgkin-Lymphome. In: Löffler H (Hrsg) Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd. 18. Lehmann, München, S 145–150Google Scholar
  133. Lennert K, Stein H, Kaiserling E (1975) Cytological and functional criteria for the classification of malignant lymphoma. Brit J Cancer 31, Suppl II: 29–43Google Scholar
  134. Lennert K, in collaboration with Mohri N, Stein H, Kaiserling E, Müller-Hermelink HK (1978) Malignant lymphomas other than Hodgkin’s disease. In: Handbuch der speziellen pathologischen Anatomie und Histologie, Bd I/3B. Springer, Berlin Heidelberg New YorkGoogle Scholar
  135. Levi JA, Wiernik PH (1977) The therapeutic implications of splenic involvement in stage III A Hodgkin’s disease. Cancer 39: 2158–2165PubMedGoogle Scholar
  136. Lewitt SH, Bloomfield CD, Lee CKK, Nesbit ME, McKenna RW (1976) Extended field radiotherapy in Non-Hodgkin’s lymphoma. Radiology 118: 457–459Google Scholar
  137. Li JG (1963) The leukocytopenic effect of focal splenic X-irradiation in leukemic patients. Radiology 80: 471–476PubMedGoogle Scholar
  138. Lichtenstein L (1953) Histiocytosis X: integration of eosinophilic granuloma of bone, Letterer-Siwe disease and Hand-Schüller-Christian disease. As related manifestations of single nosologic entity. AMA Arch Path 56: 84–102Google Scholar
  139. Lichtenstein L, Jaffe HL (1940) Eosinophilic granuloma of bone. Amer J Path 16: 595–604PubMedGoogle Scholar
  140. Lokich JJ, Frei III E, Jaffe N, Tullis J (1976) New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin’s disease. Cancer 38: 667–671PubMedGoogle Scholar
  141. Lourdes Z, Nisce G, D’Angio J, Kim JH (1973) Weekly total-skin electron-beam irradiation for mycosis fungoid es. Radiology 109: 638–686Google Scholar
  142. Lowenbraun S, Sutherland IC, Feldman MJ, Serpick AA (1971) Transformation of reticulum cell sarcoma to acute leukemia. Cancer (Philadelphia) 27: 579–585Google Scholar
  143. Lukes RJ (1963) Relationship of histologic features to clinical stages in Hodgkin’s disease. Amer J Roentgenol 90: 944–955PubMedGoogle Scholar
  144. Lukes RJ (1968) The pathologic picture of the malignant lymphomas. In: Zarafonatis CJD (ed) Proceedings of the International Conference on Leukemia-Lymphoma. Lea & Febiger, Philadelphia, pp 333–356Google Scholar
  145. Lukes RJ, Butler JJ (1966) The pathology and nomenclature of Hodgkin’s disease. Cancer Res 26: 1063–1081PubMedGoogle Scholar
  146. Lukes RJ, Butler JJ, Hicks EB (1966a) Natural history of Hodgkin’s disease as related to its pathologic picture. Cancer (Philadelphia) 19: 317–344Google Scholar
  147. Lukes RJ, Collins RD (1974) Functional approach to the classification of malignant lymphoma. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 19–30Google Scholar
  148. Lukes RJ, Collins RD (1975) New approaches to the classification of the lymphomata. Brit J Cancer 31: 1–28Google Scholar
  149. Lukes RJ, Craver LF, Hall TC, Rappaport H, Rubin P (1966b) Report of the nomenclature comittee. Cancer Res 26: 1311Google Scholar
  150. MacMahon B (1957) Epidemiological evidence on the nature of Hodgkin’s disease. Cancer (Philadlephia) 10: 1045–1054Google Scholar
  151. McKelvey EM, Moon TE (1977) Curability of Non-Hodgkin’s lymphomas. Cancer Treat Rep 61: 1185–1190PubMedGoogle Scholar
  152. Meuret G, Hoffmann G, Gmelin R (1975) Erfahrungen mit der Radiophosphor-Therapie bei Polycythaemia vera. Strahlentherapie 149: 49–54PubMedGoogle Scholar
  153. Meuret G, Fliedner TM, Schütz W, Öhl N, Afkham J, Obrecht P, Musshoff K (1971) Erfahrungen mit der extrakorporalen Blutbestrahlung bei der Behandlung der chronisch-lymphatischen Leukämie. Klin Wochenschr 49: 899–904PubMedGoogle Scholar
  154. Meuret G, Schütz W, Harris EB, Fliedner TM, Hoelzer D, Afkham J, Obrecht P, Musshoff K, Heinze V. Tourkantonis A (1969) Die Behandlung der chronisch-lymphatischen Leukämie durch extrakorporale Blutbestrahlung unter Verwendung konventioneller Strahlentherapiegeräte. Strahlentherapie 137: 429–441PubMedGoogle Scholar
  155. Meusers R, Bartels H, Brittinger G, Common H, Dühmke E, Fülle HH, Gunzer U, Heinz R, König E, Musshoff K, Pralle H, Schmalhorst U, Theml H, Krüger GRF, Lennert K (1979) Heterogenity of diffuse histiocytic lymphoma as demonstrated by the Kiel Classification. N Engl J Med: 384Google Scholar
  156. Mill WB (1975) Radiation therapy in multiple myeloma. Radiology 115: 175–178PubMedGoogle Scholar
  157. Moore MR, Bull JM, Jones SE, Rosenberg SA, Kaplan HS (1977) Sequential radiotherapy and chemotherapy in the treatment of Hodgkin’s disease: a progress report. Ann Intern Med 77: 1–9Google Scholar
  158. Moss WT, Brand WN, Battifora H (1973) Radiation oncology. Rationale, technique results, 4th ed. Mosby, St. LouisGoogle Scholar
  159. Murphy SB (1976) Non-Hodgkin’s lymphomas of childhood. In: Donaldson M, Sendel HG (eds) Trends in childhood cancer. Wiley, New York, p 31Google Scholar
  160. Murphy SB (1977) Management of childhood Non-Hodkin’s lymphoma. Cancer Treat Rep 61: 1161–1173PubMedGoogle Scholar
  161. Musshoff K (1967) Systematische prophylaktische Bestrahlung bei Systemerkrankungen (Morbus Hodgkin). Strahlentherapie Sonderbd 64, Teil B: 74–86Google Scholar
  162. Musshoff K (1968) Die Strahlentherapie der Leukosen. Internist 9: 484–489PubMedGoogle Scholar
  163. Musshoff K (1971) Prognostic and therapeutic implications of staging in extranodal Hodgkin’s disease. Cancer Res 31: 1814–1827PubMedGoogle Scholar
  164. Musshoff K (1972) Grundlagen der Strahlentherapie des Morbus Hodgkin. Indikation und Ergebnisse. Z Krebsforsch 78: 162–191Google Scholar
  165. Musshoff K (1973) Survival and relapse data in Hodgkin’s disease. Freiburg im Breisgau 1948–1969. Int Symp Hodgkin’s disease, Stanford University School of Medicine, Stanford, Calif., March 20–24, 1972. Nat Cancer Inst Monogr 36: 531–539PubMedGoogle Scholar
  166. Musshoff K (1978) Voraussetzungen und Probleme der adjuvanten Chemotherapie in Verbindung mit der primären Strahlentherapie der Nicht-Hodgkin-Lymphome unter besonderer Berücksichtigung der Histologie. Hämatologie Bluttransfusion 22: 101–114Google Scholar
  167. Musshoff K (1979) Die Strahlentherapie der Non-Hodgkin-Lymphome. Indikation und Probleme. In: Stacher A, Höcker P (Hrsg) Lymphknotentumoren. Urban & Schwar-zenberg, München Wien Baltimore, S 157–165Google Scholar
  168. Musshoff K, Boutis L (1967) Die Frage der Heilbarkeit der Lymphogranulomatose, beurteilt nach den Behandlungsergebnissen der Freiburger Medzinischen Klinik. Verh Dtsch Ges Inn Med 73: 322–329PubMedGoogle Scholar
  169. Musshoff K, Boutis L (1968) Therapy results in Hodgkin’s disease. Freiburg i.Br., 1948–1966. Cancer 21: 1100–1113PubMedGoogle Scholar
  170. Musshoff K, Leopold H (1978) On the question of the tumoricidal dose in Non-Hodgkin’s lymphomas. In: Mathé G, Seligmann M, Tubiana M (eds) Recent results in cancer research, vol 65. Springer, Berlin Heidelberg New York, S. 203–206Google Scholar
  171. Musshoff K, Schmidt-Vollmer H (1975a) Prognostic significance of primary site after radiotherapy in Non-Hodkin’s lymphomata. Brit J Cancer 31, Suppl II: 425–434Google Scholar
  172. Musshoff K, Schmidt-Vollmer H (1975b) Prognosis of Non-Hodgkin’s lymphomas with special emphasis on the staging classification. Z Krebsforsch 83: 323–341Google Scholar
  173. Musshoff K, Slanina J (1974a) Die Strahlenbehandlung der Lymphogranulomatose. Internist 15: 85–92PubMedGoogle Scholar
  174. Musshoff K, Slanina J (1974b) Stadieneinteilung der malignen Lymphome — zugleich ein Beitrag über die Bedeutung der Laparatomie mit Splenektomie. Klin Wochenschr 52: 109–117PubMedGoogle Scholar
  175. Musshoff K, Stamm H, Lümmel G, Gössel K (1964) Zur Prognose der Lymphogranulomatose. Klinisches Bild und Strahlentherapie. Freiburger Krankengut 1938–1958. Beiträge zur inneren Medizin. Schattauer, Stuttgart, S. 549–561Google Scholar
  176. Musshoff K, Boutis L, Obrecht P, Karsch T (1968a) Die Lebenserwartung bei der chronischen myeloischen Leukaemie in Abhängigkeit von der Therapie. Freiburger Ergebnisse 1945–1966. Verh Dtsch Ges Inn Med 74: 648–652PubMedGoogle Scholar
  177. Musshoff K, Renemann H, Boutis L, Afkham J (1968b) Die extranoduläre Lymphogranulomatose: Diagnose, Therapie und Prognose bei zwei unterschiedlichen Formen des Organbefalls. Ein Beitrag zur Stadieneinteilung des Morbus Hodgkin. Fort sehr Röntgenstr 104: 776–786Google Scholar
  178. Musshoff K, Boutis L, Obrecht P, Karsch T (1969) Die Lebenserwartung der chronischen myeloischen Leukaemie in Abhängigkeit von individuellen und krankheitsspezifischen Faktoren und der Therapie. Freiburger Ergebnisse 1947–66. Klin Wschr 47: 179–183PubMedGoogle Scholar
  179. Musshoff K, Oehlert W, Hamann W, Nuss A (1970a) Radiation therapy and cure in Hodgkin’s disease. Acta Radiol Ther Phys Biol 9: 289–301PubMedGoogle Scholar
  180. Musshoff K, Renemann H, Boutis L, Afkham J (1970b) The differentiation of two different types of stage IV of Hodgkin’s disease. II. International Congress of Lymphol-ogy, Miami, March 15–20, 1968. Progress in Lymphology II. Thieme, Stuttgart, pp 272–275Google Scholar
  181. Musshoff K, Schmidt-Vollmer H, Merten D (1971) Reticulum cell sarcoma: An onocological model for a system of classifying the malignant lymphoma. Europ J Cancer 7: 451–457Google Scholar
  182. Musshoff K, Hartmann C, Niklaus B, Rossner R (1974a) Results of therapy in Hodgkin’s disease. Freiburg i. Br. 1964–1971. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 206–220Google Scholar
  183. Musshoff K, Hartmann CHG, Niklaus B, Rossner R (1974b) Prognostic value of the survival, remission, and recurrence rates of Hodgkin’s disease following radiation therapy. In: Lopez GH, Bonmati J, Berry RH, Hopewell JW (eds) Radiology. Proceedings of the XIII. International Congress of Radiology, Madrid, October 15–20, 1973. Excerpta Medica, Amsterdam; American Elsevier, New York, pp 7–10Google Scholar
  184. Musshoff K, Staib J, Oehlert W, Pauli-Beisel C, Löhr G-W, Slanina J, Böttcher D (1974c) Primäre und sekundäre Laparotomie mit Splenektomie bei Patienten mit Morbus Hodgkin. Vorläufige Ergebnisse im Freiburger Krankengut. Klin Wochenschr 52: 24–29PubMedGoogle Scholar
  185. Musshoff K, Hartmann C, Niklaus B, Rossner R (1976) The prognostic significance of first and second remission in Hodgkin’s disease after first and second relapse radiotherapy. Z Krebsforsch 85: 243–270Google Scholar
  186. Musshoff K, Schmidt-Vollmer H, Lennert K, Sandritter W (1976) Preliminary clinical findings on the Kiel Classification of malignant lymphomas. Z Krebsforsch 87: 229–238Google Scholar
  187. Musshoff K, Stotzingen W von, Schmidt-Vollmer H (eingereicht) Investigation results of a comparison between the Rappaport and the Kiel Classification of the non-Hodgkin lymphomas, together with clinical data. J Cancer Res Clin OncolGoogle Scholar
  188. Neidhart B, Hartwich G, Schwemmle K, Hermanek P, Seiler G (1975) Explorative Lapa-ratomie und Splenektomie bei Lymphogranulomatose. Dtsch Med Wochenschr 100: 1487–1492Google Scholar
  189. Ochsner SF (1966) Eosinophile granuloma of bone. Experience with 20 cases. Amer J Roentgenol 97: 719–726PubMedGoogle Scholar
  190. O’Connell MJ, Wiernik PH, Brace KC, Byhardt RW, Green WH (1975) A combined modality approach to the treatment of Hodgkin’s disease; preliminary results of a prospectively randomized clinical trial. Cancer 35: 1055–1064PubMedGoogle Scholar
  191. Olmer J, Gabriel B, Bove J (1967) Zur Behandlung der chronischen myeloischen Leu-kaemie. Dtsch Röntgenkongreß 1966, Teil B, S 276–277Google Scholar
  192. Ottani S, Ehrlich JC (1940) Solitary granuloma of bone simulating primary neoplasm. Amer J Pathol 16: 479–490Google Scholar
  193. Page V, Gardner A, Karzmark CJ (1970a) Physical and dosimetric aspects of the radiotherapy of malignant lymphomas. The mantle technique. Radiology 96: 609–618PubMedGoogle Scholar
  194. Page V, Gardner A, Karzmark C (1970b) Physical and dosimetric aspects of the radiotherapy of malignant lymphomas. II. The inverted Y-technique. Radiology 96: 619 – 626PubMedGoogle Scholar
  195. Peckham MJ (ed) (1975) Non-Hodgkin’s lymphomata, Symposium held at the Royal Institution, London, October 1973. Brit J Cancer 31, Suppl IIGoogle Scholar
  196. Peters MV (1950) A study of survivals in Hodgkin’s disease treated radiologically. Amer J Roentgenol 63: 299–311Google Scholar
  197. Peters MV (1961) The place of irradiation in the control of Hodgkin’s disease. In: Proceedings of the IV. National Cancer Conference 1960. Lippincott, Philadelphia, pp 571–584Google Scholar
  198. Peters MV (1966) Prophylactic treatment of adjacent areas in Hodgkin’s disease. Cancer Res 26: 1232–1243PubMedGoogle Scholar
  199. Peters MV, Brown TC, Rideout DF (1973) Prognostic influences and radiation therapy according to pattern of disease. In: Rubin P (ed) Updated Hodgkin’s disease: B. Curability of localized disease. J Amer Med Ass 223: 53–58Google Scholar
  200. Peters MV, Hasselback R, Brown TC (1968) The natural history of the lymphomas related to the clinical classification. In: Zararonetis CJD (ed) Proceedings of the International Conference on Leukemia-Lymphoma. Lea & Febiger, Philadelphia, pp 357–370Google Scholar
  201. Peters MV, Bush RS, Brown TC, Reid J (1975) The place of radiotherapy in the control of non-Hodgkin’s lymphomata. Brit J Cancer 31, Suppl II: 386–401Google Scholar
  202. Peters MV, Middlemiss KCH (1958) Study of Hodgkin’s disease treated by irradiation. Amer J Roentgenol 79: 114–121PubMedGoogle Scholar
  203. Pfeiffer J (1965) Zur Diagnostik und Therapie des eosinophilen Knochengranuloms. Strahlentherapie 126: 42–52PubMedGoogle Scholar
  204. Pinkel D, Somone J, Hustu HO, Aur RJA (1972) Nine years experience with “total therapy” of childhood acute lymphocytic leukemia. Pediatrics 50: 246–251PubMedGoogle Scholar
  205. Pinkel D, Johnson W, Aur RJA (1975) Non-Hodgkin’s lymphoma in children. Brit J Cancer 31, Suppl II: 298–323Google Scholar
  206. Portlock CS, Rosenberg SA, Glatstein E, Levy R, Kaplan HS (1977) Failure of initial therapy for stage I, II and III Hodgkin’s disease: salvage management (Abstr). Proc Amer Soc Clin Oncol 18: 342Google Scholar
  207. Porzig KJ, Portlock CS, Robertson A, Rosenberg SA (1978) Treatment of advanced Hodgkin’s disease with B-CAVe following MOPP failure. Cancer 41: 1670–1675PubMedGoogle Scholar
  208. Prager PJ, Menges V, DiBiase M, Wurster KH, Krastel A, Assmus H (1976) Das eosinophile Knochengranulom beim Erwachsenen. Radiologe 16: 21–28PubMedGoogle Scholar
  209. Prosnitz LR, Rafael L, Montalvol BA, Fischer DB, Silberstein AB, Berger DS (1978) Treatment of stage III A Hodgkin’s disease: Is radiotherapy alone adequate? Int J Radiat Oncol Biol Phys 4: 781 – 787PubMedGoogle Scholar
  210. Rai KR, Sawithky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46: 219–234PubMedGoogle Scholar
  211. Rajewski B (1954) Strahlendosis und Strahlenanwendung. Thieme, StuttgartGoogle Scholar
  212. Rappaport H (1966) Tumors of the hematopoetic system. Armed Forces Institute of Pathology, Sect 3, fase 8. Washington DC, pp 91–156Google Scholar
  213. Pappaport H, Strum SB (1970) Vascular invasion in Hodgkin’s disease: Its incidence and relationship to the spread of the disease. Cancer (Philadlephia) 25: 1304–1313Google Scholar
  214. Rappaport H, Winter WJ, Hicks EB (1956) Follicular lymphoma: A reevaluation of its position in the scheme of malignant lymphomas, based on a survey of 253 cases. Cancer (Philadelphia) 9: 729–821Google Scholar
  215. Ratkóczy N (1936) Herdvernichtungsdosen in der Röntgentherapie der Lymphogranulomatose. Strahlentherapie 56: 325–336Google Scholar
  216. Renner H (1973) Strahlentherapeutische Aspekte des multiplen Myeloms. Strahlentherapie 146: 15–23PubMedGoogle Scholar
  217. Revol L, Cordat M, Rouhier D, Clavel M, Jeune R, Guyon JM, Chassard JL, Papillon J (1974) Quelques considération sur la radiothérapie dans la leucémie myéloide chronique. Strahlentherapie 148: 572–578PubMedGoogle Scholar
  218. Riehm H, Gadner H, Weite K (1977) Die West-Berliner Studie zur Behandlung der akuten lymphoblastischen Leukämie des Kindes — Erfahrungsbericht nach 6 Jahren. Klin Pädiat 189: 89–102Google Scholar
  219. Robb-Smith AHT (1947) The lymph node biopsy. In: Recent advances in clinical pathology. Churchill, London, pp 350–370Google Scholar
  220. Rosenberg SA (1961) Lymphosarcoma: A review of 1269 cases. Medicine (Baltimore) 40: 31–84Google Scholar
  221. Rosenberg SA (1966) Report of the Staging Committee of Hodgkin’s disease. Cancer Res 26: 1310Google Scholar
  222. Rosenberg SA, Kaplan HS (1966) Evidence for an orderly progression in the spread of Hodgkin’s disease. Cancer Res 26: 1225–1230PubMedGoogle Scholar
  223. Rosenberg SA, Kaplan HS (1970) Hodgkin’s disease and other malignant lymphomas. Calif Med 113: 23–38PubMedGoogle Scholar
  224. Rosenberg SA, Kaplan HS (1975a) The management of stage I, II and HI Hodgkin’s disease with combined radiotherapy and chemotherapy. Cancer (Philadelphia) 35: 55–63Google Scholar
  225. Rosenberg SA, Kaplan HS (1975b) Clinical trials in the non-Hodkin’s lymphomata at Stanford University experimental design and preliminary results. Brit J Cancer 31, Suppl II: 456–464Google Scholar
  226. Rosenberg SA, Boiron M, DeVita VT, Johnson RE, Lee BJ, Ullmann JE, Viamonte M (1971) Report of the Committee on Hodgkin’s disease staging procedures. Cancer Res 31: 1862–1863PubMedGoogle Scholar
  227. Rosenberg SA, Kaplan HS, Glatstein E, Portlock SC (1977) The role of adjuvant MOPP in the radiation therapy of Hodgkin’s disease: a progress report after eight years on the Stanford trials. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer. Elsevier/North Holland, Amsterdam, pp 505–515Google Scholar
  228. Rosenberg SA, Kaplan HS, Glatstein EJ, Portlock CS (1978) Combined modality therapy of Hodgkin’s disease — Report of the Stanford trials. Cancer 42: 991–1000PubMedGoogle Scholar
  229. Rosenthal SR (1936) Significance of tissue lymphocytes in the prognosis of Lymphogranulomatose. Arch Path 21: 628–646Google Scholar
  230. Rous P (1911) Transmission of a malignant new growth by means of cell-free filtrate. J Amer Med Ass 56: 198–201Google Scholar
  231. Rühl U (1977) Ganzkörperbestrahlung bei Non-Hodgkin-Lymphomen als Alternative zur Chemotherapie. Strahlentherapie 153: 299–303PubMedGoogle Scholar
  232. Rühl U, Johnson RE (1975) Ganzkörperbestrahlung in der Behandlung der chronischen Lymphadenose. Vortrag; Deutsch-Österr. Hämatologen-Kongreß, Bad NauheimGoogle Scholar
  233. Salzmann JR, Kaplan HS (1971) Effect of splenectomy on hematologic tolerance during total lymphoid radiotherapy of patients with Hodgkin’s disease. Cancer 27: 471–478Google Scholar
  234. Schein PS, Chabner BA, Canellos GP, Young RC, DeVita VT Jr (1975) Non-Hodgkin’s lymphoma: Patterns of relapse from complete remission after combination chemotherapy. Cancer 35: 354–357PubMedGoogle Scholar
  235. Schmidt-Vollmer H, Musshoff K, Lennert K, Sandritter W, Stiefelhaben H (1975) Vorläufige Befunde zur Prognose der Kiel-Klassifikation der malignen Non-Hodgkin-Lymphome. Gemeinsame Tagung der Deutschen und Österreichischen Gesellschaft für Hämatologie, Bad Nauheim, 29.9–1.10.1975Google Scholar
  236. Schmitz H, Scherer H (1972) IgM antibodies to Epstein-Barr virus in infectious mononucleosis. Arch Ges Virusforsch 37: 332–339PubMedGoogle Scholar
  237. Schoen D, Bauer R (1968) Ergebnisse der Milzbestrahlung bei 175 Fällen mit chronisch-myeloischer Leukämie. Strahlentherapie 135: 1–10PubMedGoogle Scholar
  238. Scott RB (1957) Leukaemia: chronic lymphatic leukaemia. Lancet 1957 I: 1162–1167Google Scholar
  239. Sherins RJ, DeVita VT Jr (1973) Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy. Ann Intern Med 79: 216–220PubMedGoogle Scholar
  240. Slanina J, Musshoff K, Rahner T, Stiassny R, in cooperation with: Barmeyer J, Baumeister L, Berger W, Dichgans J, Gehring G, Grub R, Heite H-J, Hennekeuser HH, Herkel L, Krüssmann K, Kuphal K, Löhr G-W, Möbius W, Rossner R, Schmidt-Vollmer H (1977) Long-term side effects in irradiated patients with Hodgkin’s disease. Int J Radiat Oncol Biol Phvs 2: 1–19Google Scholar
  241. Slanina J, Kuphal K, Riegsinger A (1980) Anwendung des Split-Course-Verfahrens bei der total nodalen Systembestrahlung der Hodgkin’schen Erkrankung. Strahlentherapie 156: 18–25PubMedGoogle Scholar
  242. Smetana HF, Cohen BM (1956) Mortality in relation to histologic type in Hodgkin’s disease. Blood 11: 211 – 224PubMedGoogle Scholar
  243. Speck B (1975) Möglichkeiten und Probleme der klinischen Knochenmarkstransplantation. Med Welt (Berlin) 26: 39–43Google Scholar
  244. Spiegelman S, Axel R, Baxt W, Jufe D, Schlom J (1974) Human cancer and animal viral oncology. Cancer (Philadelphia) 34: 1406–1420Google Scholar
  245. Stacher A, Theml H, Waldner R (1975) Klinik der malignen Non-Hodgkin-Lymphome entsprechend der Kieler Klassifikation: Immunocytom und chronische lymphatische Leukämie. Gemeinsame Tagung der Deutschen und Österreichischen Gesellschaft für Hämatologie, Bad Nauheim, 29.9.–1.10.1975Google Scholar
  246. Stein H (1976) Klassifikation der malignen Non-Hodgkin-Lymphome aufgrund gemeinsamer morphologischer und immunologischer Merkmale zwischen normalen und neoplastischen Zellen. Immun Infekt 4: 52–69 und 95–109PubMedGoogle Scholar
  247. Stein RS, Hilborn RM, Flexner JM, Bolin M, Stroup S, Reynolds V, Krantz S (1978) Anatomical sub stages of stage III Hodgkin’s disease. Implications for staging, therapy and experimental design. Cancer 42: 429–436PubMedGoogle Scholar
  248. Stenfert-Kroese WF, Cleton FJ, Somers R (1974) Leukaemic progression in lympho-mata. Symposium on Non-Hodgkin’s lymphomata. London, October 8–10 1973. Brit J Cancer 30, Suppl II: 102–106Google Scholar
  249. Strauchen JA, Young RC, DeVita VT Jr, Anderson T, Fantone YC, Berard CW (1978) Clinical relevance of the histopathological sub classificai ion of diffuse “histocytic” lymphome. New Engl J Med 299: 1382–1387PubMedGoogle Scholar
  250. Strickstrock KH, Musshoff K, Boutis L (1967) Methode der zusätzlichen prophylaktischen Bestrahlung bei der Lymphogranulomatose. Strahlentherapie 133: 337–348PubMedGoogle Scholar
  251. Symposium International organisé à Paris de 15 Février 1965 sous la direction de M. Maurice Tubiana: La radiothérapie de la maladie de Hodgkin. J Radiologie, Suppl 47: 1–176Google Scholar
  252. Symposium (1971) Staging in Hodgkin’s disease. Ann Arbor/Michigan, April 26–28, 1971. Cancer Res 31: 1707–1870Google Scholar
  253. Symposium International on Hodgkin’s disease (1973) Stanford (Calif), March 20–24, 1972. Natl Cancer Inst Monogr 36: 1 – 587Google Scholar
  254. Symposium on Non-Hodgkin’s lymphomata (1975) London, October 8–12, 1973. Pckham MJ (ed). Brit J Cancer 30, Suppl II: 1–511Google Scholar
  255. Teschendorf W (1927) Über Bestrahlung des ganzen menschlichen Körpers bei Blutkrankheiten. Strahlentherapie 26: 720–728Google Scholar
  256. Tschendorf W (1953) Die Teleröntgentherapie. Thieme, StuttgartGoogle Scholar
  257. Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodell BW, Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Singer J, Stevens M, Storb R, Weiden PL (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation. Blood 49: 511 – 533PubMedGoogle Scholar
  258. Todd IDH (1965) Treatment of solitary plasmacytoma. Klin Radiol 16: 385–399Google Scholar
  259. Töppner R (1952) Zur Behandlung des eosinophilen Granulomes mit Röntgenstrahlen. Strahlentherapie 88: 362–376PubMedGoogle Scholar
  260. Tubiana M, Attie E, Flamant R, Gerard-Marchant R, Hayat M (1971) Prognostic factors in 454 cases of Hodgkin’s disease. Cancer Res 31: 1801–1810PubMedGoogle Scholar
  261. Tulinius H (1974) Epidemiology of Hodgkin’s disease. XI. International Cancer Congress, Florence, October 20–26, 1974Google Scholar
  262. Veronesi U. Musumeci R, Pizzetti F, Gennari L, Bonadonna G (1974) The value of staging laparotomy in Non-Hodgkin’s lymphomas. Cancer (Philadelphia) 33: 446–459Google Scholar
  263. Vianna NJ, Koegh MD, Polan AK, Greenwald P (1974) Hodgkin’s disease mortality among physicians. Lancet 1974 II: 131–132Google Scholar
  264. Wachtler F (1961) Über die Strahlenbehandlung des eosinophilen Knochengranuloms. Krebsarzt 16: 193–197PubMedGoogle Scholar
  265. Wannenmacher M, Slanina J, Kuphal K, Bruggmoser G (1978) Gegenwärtiger Stand der Großfeldtechnik unter Megavoltbedinungen bei der Strahlentherapie der Hodgkin’-schen Erkrankung — Grundlagen, Durchführung, Nebenwirkungen. Radiologe 18: 371–387PubMedGoogle Scholar
  266. Watanabe A, Sullivan MP, Sutow WW, Wilbur R (1973) Undifferentiated lymphoma of non-Burkitt’s type. Amer J Dis Child 125: 57–61PubMedGoogle Scholar
  267. Wehinger H, Slanina J, Jacobi H, Musshoff K, Dietz V, Sauer M, Dilger M (1974) Prophylactic central nervous system therapy with cranial irradiation and intrathecal methotrexate in acute lymphoblastic leukaemia of childhood. Strahlentherapie 148: 590–598PubMedGoogle Scholar
  268. Weller S, Glatstein E, Castellino RA, Kaplan HS, Rosenberg SA (1977) Initial relapse in previously treated Hodgkin’s disease. — II. Retrograde transdiaphragmatic extension. Int J Radiat Oncol Biol Phys 2: 863–872PubMedGoogle Scholar
  269. Werf-Messing B van der (1968) Reticulum cell sarcoma and lymphosarcoma. A retrospective study of potential survival in loco-regional disease. Europ J Cancer 4: 549 – 557Google Scholar
  270. Worthy TS (1975) The place of laparotomy in the cure of Hodgkin’s disease. 3. Kongreß der Europäischen Radiologischen Gesellschaft, Edinburgh, 22.–27. Juni 1975Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1980

Authors and Affiliations

  • K. Musshoff
  • J. Slanina

There are no affiliations available

Personalised recommendations